43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam Increased incidence of fractures in women who received rosiglitazone in ADOPT (A Diabetes Outcome Progression Trial)
Kahn SE, Zinman B, Lachin JM, Haffner SM, Herman WH, Holman RR, Kravitz BG, Yu D, Heise MA, Aftring RP, Viberti G; Diabetes Outcome Progression Trial (ADOPT) Study Group
Diabetologia 2007;50:Suppl 1:S37 [Abstract]
43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam Greater reductions in C-reactive protein with rosiglitazone than with glyburide or metformin despite greater weight gain
Haffner SM, Kahn SE, Zinman B, Holman R, Viberti GF, Herman WH, Lachin JM, Kravitz BG, Heise MA
Diabetologia 2007;50:Suppl 1:S36 [Abstract]
43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam Determinants of monotherapy failure in ADOPT (A Diabetes Outcome Progression Trial)
Holman RR, Kahn SE, S. Haffner M, Zinman B, Viberti GF, Herman WH, Lachin JM, Kravitz BG, Heise MA
Diabetologia 2007;50:Suppl 1:S356 [Abstract]
43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam ADOPT: The effectiveness of metformin versus glyburide in type 2 diabetes
Herman WH, Haffner SM, Kahn SE, Zinman B, Holman RR, Viberti GF, Lachin JM, Kravitz BG, Heise MA
Diabetologia 2007;50:Suppl 1:S362 [Abstract]
Diabetes Trials Unit, OCDEM, Churchill Hospital, Old Road, Headington, Oxford, OX3 7LJ
Tel: +44 (0)1865 857240 Email: dtu@dtu.ox.ac.uk
